ASX - Delayed Quote AUD

Arovella Therapeutics Limited (ALA.AX)

0.0800
+0.0040
+(5.26%)
At close: 4:10:57 PM GMT+10
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
144.5000
17
405.8980
295.8100
257.3470
Cost of Revenue
--
--
203.5200
207.0560
222.7500
Gross Profit
144.5000
17
202.3780
88.7540
34.5970
Operating Expense
10,007.1920
10,828.2610
9,883.1170
7,685.1960
4,700.7120
Operating Income
-9,862.6920
-10,811.2610
-9,680.7390
-7,596.4420
-4,666.1150
Net Non Operating Interest Income Expense
297.5810
130.1040
9.3460
-190.8750
-26.7520
Other Income Expense
3,303.2640
1,935.1220
-509.9580
-833.2710
-354.5980
Pretax Income
-6,261.8470
-8,746.0350
-10,181.3510
-8,620.5880
-5,047.4650
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-6,261.8470
-8,746.0350
-10,181.3510
-8,620.5880
-5,047.4650
Basic EPS
-0.01
-0.01
-0.01
-0.02
-0.02
Diluted EPS
-0.01
-0.01
-0.01
-0.02
-0.02
Basic Average Shares
1,018,319.5480
941,423.3560
711,483.4010
549,623.8380
330,893.2810
Diluted Average Shares
1,018,319.5480
941,423.3560
711,483.4010
549,623.8380
330,893.2810
Net Income from Continuing & Discontinued Operation
-6,261.8470
-8,746.0350
-10,181.3510
-8,620.5880
-5,047.4650
Normalized Income
-6,261.8470
-8,746.0350
-8,622.6300
-7,787.3170
-3,786.1970
Interest Income
297.5810
138.7350
30.0200
3.8450
6.5420
Interest Expense
--
8.6310
20.6740
194.7200
33.2940
Net Interest Income
297.5810
130.1040
9.3460
-190.8750
-26.7520
EBIT
-9,810.1600
-8,737.4040
-10,160.6770
-8,425.8680
-5,014.1710
EBITDA
-9,741.1060
-8,694.4250
-9,323.5000
-7,874.3800
-4,361.9950
Reconciled Cost of Revenue
--
--
203.5200
207.0560
222.7500
Reconciled Depreciation
69.0540
42.9790
837.1770
551.4880
652.1760
Net Income from Continuing Operation Net Minority Interest
-6,261.8470
-8,746.0350
-10,181.3510
-8,620.5880
-5,047.4650
Total Unusual Items Excluding Goodwill
--
--
-1,558.7210
-833.2710
-1,261.2680
Total Unusual Items
--
--
-1,558.7210
-833.2710
-1,261.2680
Normalized EBITDA
-9,741.1060
-8,694.4250
-7,764.7790
-7,041.1090
-3,100.7270
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
6/30/2021 - 1/22/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VBS.AX Vectus Biosystems Limited
0.0480
0.00%
 
1AD.AX AdAlta Limited
0.0020
0.00%
 
1AI.AX Algorae Pharmaceuticals Limited
0.0050
0.00%
 
IXC.AX Invex Therapeutics Ltd
0.0800
-1.23%
 
RNV.AX RENERVE FPO [RNV]
0.1100
0.00%
 
CMB.AX Cambium Bio Limited
0.2300
-4.17%
 
TRP.AX Tissue Repair Ltd
0.1800
0.00%
 
BTC.AX BTC Health Limited
0.0520
0.00%
 
MEM.AX Memphasys Limited
0.0040
0.00%
 
AVE.AX Avecho Biotechnology Limited
0.0040
0.00%